CytomX Therapeutics (CTMX) Short-term Investments (2015 - 2026)
CytomX Therapeutics (CTMX) recorded Short-term Investments of $313.06 million in Q2 2026, up 187.1% from $109.05 million a year earlier but down 1.5% from the prior quarter.
CytomX Therapeutics (CTMX) Short-term Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics reported Short-term Investments of $124.39 million, up 98.8% from FY2024.
- Annual Short-term Investments has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $62.57 million in FY2024 (-60.2%), $157.34 million in FY2023 and $99.7 million in FY2021 (-19.8%).
- Quarterly Short-term Investments has ranged from $5,000 in Q3 2021 to $317.88 million in Q1 2026 over the past five years.
- On a year-over-year basis, Short-term Investments has increased for five consecutive quarters, with growth averaging 130.3% over the last eight quarters.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 885.7% in Q2 2022, against a decline of 100.0% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $317.88 million (Q1 2026), $124.39 million (Q4 2025) and $109.44 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 313.06 Mn |
| Mar 31, 2026 | 317.88 Mn |
| Dec 31, 2025 | 124.39 Mn |
| Sep 30, 2025 | 109.44 Mn |
| Jun 30, 2025 | 109.05 Mn |
| Mar 31, 2025 | 32.28 Mn |
| Dec 31, 2024 | 62.57 Mn |
| Sep 30, 2024 | 77.01 Mn |
| Jun 30, 2024 | 93.94 Mn |
| Mar 31, 2024 | 114.10 Mn |
| Dec 31, 2023 | 157.34 Mn |
| Sep 30, 2023 | 168.09 Mn |
| Jun 30, 2023 | 123.32 Mn |
| Mar 31, 2023 | 148.15 Mn |
| Sep 30, 2022 | 99.25 Mn |
| Jun 30, 2022 | 98.88 Mn |
| Mar 31, 2022 | 99.04 Mn |
| Dec 31, 2021 | 99.70 Mn |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 10.03 Mn |
CytomX Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=CTMX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();